EMCURE PHARMACEUTICALS
Back to Balance Sheet
|
EMCURE PHARMACEUTICALS Last 5 Year Net Current Assets History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Net Current Assets (Including Current Investments) | ₹1,700 Cr | ₹1,888 Cr | ₹1,044 Cr | ₹817 Cr | ₹459 Cr |
What is the latest Net Current Assets ratio of EMCURE PHARMACEUTICALS ?
| Year | Net Current Assets |
|---|---|
| Mar2026 | ₹1,700 Cr |
| Mar2025 | ₹1,888 Cr |
| Mar2024 | ₹1,044 Cr |
| Mar2023 | ₹817 Cr |
| Mar2022 | ₹459 Cr |
How is Net Current Assets of EMCURE PHARMACEUTICALS Trending?
| Years | Net Current Assets | % Change | |
|---|---|---|---|
| Mar2026 | ₹1,700 Cr | -9.95 | |
| Mar2025 | ₹1,888 Cr | 80.80 | |
| Mar2024 | ₹1,044 Cr | 27.83 | |
| Mar2023 | ₹817 Cr | 77.83 | |
| Mar2022 | ₹459 Cr | - | |
Compare Net Current Assets of peers of EMCURE PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| EMCURE PHARMACEUTICALS | ₹44,314.9 Cr | -0.1% | 30.9% | 68.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹452,299.0 Cr | 1% | 7.5% | 7.9% | Stock Analytics | |
| DIVIS LABORATORIES | ₹297,325.0 Cr | 0.8% | 22.8% | 71.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹178,727.0 Cr | 0.2% | 1.9% | 20.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹116,145.0 Cr | 0.8% | 12.2% | 12.3% | Stock Analytics | |
| CIPLA | ₹114,312.0 Cr | 1.5% | 6.4% | -7.8% | Stock Analytics | |
EMCURE PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| EMCURE PHARMACEUTICALS | -0.1% |
30.9% |
68.1% |
| SENSEX | 2.9% |
13.9% |
-0.8% |
You may also like the below Video Courses